-
This novel agent, which inhibits interactions between beta amyloid (Ab) and metal ions, holds promise as a therapeutic agent for Alzheimer's disease.
-
The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions.
-
Gingko biloba does not prevent Alzheimer's disease.
-
The monoclonal antibody alemtuzumab, that targets the CD52 receptor on lymphocytes, reduced acute exacerbations and early disability by 70%.
-
The use of sustained pulsed dosing of intravenous immunoglobulin (IVIG) may be useful for treating multiple sclerosis (MS) patients with corticosteroid refractory optic neuritis.
-
Excessive use of denture cream, which contains high concentrations of zinc, may cause copper deficiency nervous system syndromes.
-
Generalized autonomic failure (GAF) in the presence of a sensory neuropathy strongly suggests amyloidosis.
-
-
This study examines and describes the occurrence of an inverse neurovascular coupling response in peri-contusional brain tissue as a potential and novel mechanism for secondary brain injury.
-
In addition to autoantibodies directed against the acetylcholine receptor (AchR) and the receptor-associated protein muscle-specific tyrosine kinase (MuSK) patients with myasthenia gravis (MG) demonstrate a host of other antibodies.
